Polaryx Therapeutics, Inc. · NASDAQ:PLYX

Alex Keun Mo Yang reported a 48.00% stake in Polaryx Therapeutics, Inc. (Schedule 13D)

Event Jan 29, 2026 · Filed Feb 5, 2026

Alex Keun Mo Yang reported a 48.00% stake in Polaryx Therapeutics, Inc., 22,744,796 shares, with active intent on Jan 29, 2026. Filed Feb 5, 2026 (Schedule 13D).

Stake
48.00%
Shares
22,744,796
Intent
Active
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Mstone Partners Healthcare Limited47.40%22,452,954
MBstone Biotech Flagship Limited0.40%183,560
Mstone Pediaorphan Singapore I Pte. Limited0.20%108,282
Alex Keun Mo Yang48.00%22,744,796

Source

View original at SEC

Related